JPCCM
EIGR

J&P (China) Capital Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

J&P (China) Capital Management’s Portfolio EIGR Stock Details EIGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-16
Closed -$8K – 20
2015
Q3 		$8K Hold
16
– – ﹤0.01% 19
2015
Q2 		$9K Buy
+16
New +$44.3K ﹤0.01% 23

Other funds holding EIGR

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

J&P (China) Capital Management's EIGR Position: Q4 2015 in Review

J&P (China) Capital Management sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q4 2015, closing a stake of 16 shares — an estimated $8K sold.

J&P (China) Capital Management first reported a position in EIGR in Q2 2015 and held it in 2 quarters. The position peaked at $9K in Q2 2015. 41 funds tracked by Wall St. Rank hold EIGR as of Q4 2015.

  • J&P (China) Capital Management reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • J&P (China) Capital Management sold 16 Eiger BioPharmaceuticals, Inc. shares in Q4 2015, an estimated $8K.
  • J&P (China) Capital Management first reported a position in Eiger BioPharmaceuticals, Inc. in Q2 2015 and held it in 2 quarters.
  • J&P (China) Capital Management's Eiger BioPharmaceuticals, Inc. position peaked at $9K in Q2 2015.
  • 41 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q4 2015.

Based on J&P (China) Capital Management's 13F filing for Q4 2015, filed 29 Jan 2016.